Glypharma is Biotechnology in Canada that focus on rare gastrointestinal diseases business. Founded in 2012. They cover business area such as developer, novel clinical therapy, short bowel syndrome, patient, hematological malignancy, myelotoxic therapy.
2012
( 12 years old in 2024 )
Rare Gastrointestinal Diseases
-
1188 Union
Suite 504
Montreal, Quebec H3B 0E5
Canada
Private
developernovel clinical therapyshort bowel syndromepatienthematological malignancymyelotoxic therapy
* We use standard office opening hours in near Glypharma's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Glypharma is Biotechnology business from Canada that founded in 2012 (12 years old in 2024), Glypharma business is focusing on Rare Gastrointestinal Diseases.
Glypharma headquarter office and corporate office address is located in 1188 Union Suite 504 Montreal, Quebec H3B 0E5 Canada.
Glypharma was founded in Canada.
In 2024, Glypharma is currently focus on rare gastrointestinal diseases sector.
Above is snippet of Google Trends for "rare gastrointestinal diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Glypharma, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
